Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Robert Nelsen - aVenture Research

Robert Nelsen

AddedMar 31, 2024

UpdatedOct 11, 2026

Robert Nelsen

Robert Nelsen

Co-Founder, Arch Venture Partners

Robert Nelsen's Career

Arch Venture Partners

Robert Nelsen's Co-Investors

Anne WojcickiCo-invested · Gameto Series A

Thomas TullCo-invested · Colossal Biosciences Series A

Cindy CrawfordCo-invested · Katalyst Series A

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Robert Nelsen's Investments

8 investments since 2014

7 operating · 1 inactive

Investments view

Group by

2022

3

Katalyst
Series A · October 2022$26M
Series A · October 2022
Colossal Biosciences
Series A · March 2022$60M
Series A · March 2022
Gameto
Series A · January 2022$20M
Series A · January 2022

2021

1

Neuralink
Series C · July 2021$205M
Series C · July 2021

2019

1

Gali Health
Seed · June 2019$2M
Seed · June 2019

2018

1

Wisdo
Convertible Note · June 2018$4.1M
Convertible Note · June 2018

2016

1

Elysium Health
Series B · December 2016$20M
Series B · December 2016

2014

1

Ootu
Seed · July 2014$325k
Seed · July 2014

Investment FirmChicago, IL, US

Co-Founder

NeurogesX

$135.4MSan Mateo, CA, US

Board Member· Board

Denali Therapeutics

Public$622MSan Francisco, CA, US

Board Member· Board

Vir Biotechnology

Public$908.6MSan Francisco, CA, US

Board Member· Board

Beam Therapeutics

Public$689MCambridge, MA, US

Board Member· Board

Wisdo

New York City, NY, US

Board Member· Board

Ensemble Discovery

Series B$30MCambridge, MA, US

Board Member· Board

Arivale

$52.6MSeattle, WA, US

Board Member· Board

Insitro

Series C$643MSouth San Francisco, CA, US

Board Member· Board

Resilience

Series D$2.5BBlue Ash, OH, US

Board Member· Board

Maze Therapeutics

Public$381MSouth San Francisco, CA, US

Board Member· Board

Grail

Public$2BMenlo Park, CA, US

Board Member· Board

Sapphire Energy

$376.5MSan Diego, CA, US

Board Member· Board

Rande GerberCo-invested · Katalyst Series A

Charles HoskinsonCo-invested · Colossal Biosciences Series A

Paris HiltonCo-invested · Colossal Biosciences Series A

Milad AlucozaiCo-invested · Colossal Biosciences Series A

Sam AltmanCo-invested · Neuralink Series C

People Similar to Robert Nelsen

Johannes FruehaufCo-Founder · Mission BioCapital

Chris DarbyBoard Member · In-Q-Tel

Julie SunderlandManaging Director · Biomatics Capital Partners

Andrew FirlikCo-Founder · Jazz Venture Partners

Mori ArkinFounder & Chairman · Arkin Capital

Enke BashllariFounder · Arkitekt Ventures

Min XiangminCo-Founder · Decheng Capital

Recent news

Oratomic raises $475M for neutral-atom quantum computing, Universal Quantum nets $100M+SiliconANGLE · 2026

Exclusive | Quantum Startup Oratomic Now Worth $5.4 Billion After Series-B FundingWall Street Journal · 2026

Oratomic raises $300M to build a viable quantum computer that needs only 20K qubitsTechCrunch · 2026

Leadership at Arch Venture Partners

Keith CrandellCo-Founder

Clinton BybeeCo-Founder

Steve LazarusCo-Founder

Similar to Arch Venture Partners

Atlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29

Leadership at NeurogesX

Brett RobertsonCo-Founder

Wendye RobbinsCo-Founder

Similar to NeurogesX

4e TherapeuticsAustin, TX, USPain Therapiesest. 20194e TherapeuticsAustin, TX, US · est. 2019

4E Therapeutics innovates therapies for chronic neuropathic pain, migraine, and acute pain management.

Series A · $7.2M7

NeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30

NeuropathixDoylestown, PA, USTherapeuticsest. 2010NeuropathixDoylestown, PA, US · est. 2010

Neuropathix: An American biopharmaceutical firm specializing in R&D of pain management therapies.

BiolystBrooklyn Park, MN, USPain Managementest. 2010BiolystBrooklyn Park, MN, US · est. 2010

Realief™ Neuropathy Centers offers patented, data-backed treatments for peripheral neuropathy, aiming to bring real relief nationwide.

Leadership at Denali Therapeutics

Ryan WattsCo-Founder

Tom StockyBoard Member

Steve KrognesBoard Member

Jay FlatleyBoard Member

David SchenkeinBoard Member

Marc Tessier-LavigneBoard Member

Similar to Denali Therapeutics

Lysosomal TherapeuticsCambridge, MA, USDrug Developmentest. 2011Lysosomal TherapeuticsCambridge, MA, US · est. 2011

US-based Lysosomal Therapeutics Inc innovates in neurodegeneration research, developing treatments for severe neurological diseases.

Series A · $24.8M5

Leadership at Vir Biotechnology

Phillip A. SharpBoard Member

Elliott SigalBoard Member

Rob PerezBoard Member

Louis PickerCo-Founder

Klaus FruehCo-Founder

George ScangosBoard Member

Similar to Vir Biotechnology

Virion TherapeuticsNewark, DE, USImmunotherapy, Vaccinesest. 2018Virion TherapeuticsNewark, DE, US · est. 2018

Virion Therapeutics: A global biotech firm innovating vaccines for cancers and chronic viral infections.

Series A · $14.1M8

Leadership at Beam Therapeutics

John EvansBoard Member

Graham CooperBoard Member

J. Keith JoungCo-Founder

Feng ZhangCo-Founder

Carole HoBoard Member

Similar to Beam Therapeutics

Editas MedicineCambridge, MA, USGene Editing, Therapiesest. 2013Editas MedicineCambridge, MA, US · est. 2013

Editas Medicine, Inc.: A clinical-stage biotech firm pioneering CRISPR-based therapies for rare diseases.

Public · $931.6M226

Leadership at Ensemble Discovery

David LiuCo-Founder

Doug ColeBoard Member

Similar to Ensemble Discovery

Ensem TherapeuticsMedford, MA, USDrug Discoveryest. 2021Ensem TherapeuticsMedford, MA, US · est. 2021

ENSEM Therapeutics: A biotech firm specializing in drug discovery and development for complex oncology targets.

Series A · $77M33

Exo TherapeuticsCambridge, MA, USDrug Discoveryest. 2018Exo TherapeuticsCambridge, MA, US · est. 2018

Exo Therapeutics: Pioneering drug discovery and development with innovative ExoSightTM technology.

Series B · $103M37

Alcinous PharmaceuticalsRumford, RI, USDrug Discoveryest. 2016Alcinous PharmaceuticalsRumford, RI, US · est. 2016

Alcinous Pharmaceuticals: Innovating in drug discovery for oncology and other diseases.

EsanexIndianapolis, IN, USDrug Developmentest. 2011EsanexIndianapolis, IN, US · est. 2011

Esanex, Inc.: An Indianapolis-based pharmaceutical company specializing in drug development.

Series B · $15M2

Leadership at Arivale

Clayton LewisBoard Member

Dan LevitanBoard Member

Nathan PriceCo-Founder

Leroy HoodCo-Founder

Similar to Arivale

AvanteSeattle, WA, USSoftwareest. 2023AvanteSeattle, WA, US · est. 2023

Avante, founded in 2023, is a Seattle-based software company.

Leadership at Insitro

Vijay PandeBoard Member

Roger PerlmutterBoard Member

Daphne KollerCEO

Daphne KollerCEO

Paul McCrackenBoard Member

Similar to Insitro

MithrlSan Francisco, CA, USest. 2023MithrlSan Francisco, CA, US · est. 2023

Mithrl builds AI infrastructure and biomedical world models for biopharma R&D teams.

Series A · $24M24

Recent news

Resilience Further Advances North American Manufacturing Strategy TransformationNational Resilience · 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine SupplyNational Resilience · 2026

Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing CapabilitiesNational Resilience · 2026

Leadership at Resilience

Rahul SinghviCEO

Raj ShahBoard Member

Bob KerreyBoard Member

Frances ArnoldBoard Member

Sue Desmond-HellmannBoard Member

George BarrettBoard Member

Similar to Resilience

ResilienceHanover, MD, USBiomanufacturing, Drug Developmentest. 1995ResilienceHanover, MD, US · est. 1995

Resilience: Advanced cybersecurity solutions provider, ensuring network availability and uncompromised security.

Series A · $10M30

Leadership at Maze Therapeutics

Catherine SohnBoard Member

Jason ColomaBoard Member

Richard SchellerBoard Member

Andy TranBoard Member

Jeffrey TongBoard Member

Dan SpiegelmanBoard Member

Similar to Maze Therapeutics

Mahzi TherapeuticsSan Mateo, CA, USBiotechest. 2020Mahzi TherapeuticsSan Mateo, CA, US · est. 2020

Mahzi Therapeutics: A California-based healthcare and biotech firm, founded in 2020.

Series A · $47.3M13

Leadership at Grail

George GolumbeskiBoard Member

Brook ByersBoard Member

Jeff DeanBoard Member

Jeff HuberBoard Member

William H. RastetterBoard Member

Similar to Grail

EarliSouth San Francisco, CA, USCancer Treatmentsest. 2018EarliSouth San Francisco, CA, US · est. 2018

Earli Inc., a California-based biotechnology company, specializes in developing cancer treatments.

Series A · $59.9M45

Leadership at Sapphire Energy

Robert ShapiroBoard Member

Nathaniel DavidFounder

Steve GoldbyBoard Member

Cynthia WarnerCEO

Kristina BurowBoard Member

Similar to Sapphire Energy

SGP BioenergyNew York City, NY, USBioenergy, BiofuelSGP BioenergyNew York City, NY, US

SGP BioEnergy: Developing and producing integrated bioenergy products for a sustainable future.

Arch Development PartnersChicago, IL, USest. 2001

Arch Development PartnersChicago, IL, US · est. 2001

ARCH Development Partners, L.L.C. is a US-based venture capital firm serving various clients.

Investment Firm30

Archer Venture CapitalLos Angeles, CA, USest. 2010Archer Venture CapitalLos Angeles, CA, US · est. 2010

Archer Venture Capital: An investment and advisory firm for start-ups and entrepreneurs.

Investment Firm8

Archina Capital PartnersRhode Island, USest. 2015Archina Capital PartnersRhode Island, US · est. 2015

ARCHina Capital: Funding next-gen companies with global potential through venture capital.

Investment Firm5

AlectorSan Francisco, CA, USTherapeuticsest. 2013

AlectorSan Francisco, CA, US · est. 2013

Alector, Inc.: A clinical-stage biopharmaceutical firm in San Francisco, innovating therapies for brain disorders.

Public · $269.5M273

Link MedicineCambridge, MA, USMedical Productsest. 2005Link MedicineCambridge, MA, US · est. 2005

Link Medicine Corp: A US-based provider of innovative therapies and medical products for neurodegenerative diseases.

Public · $64.8M30

Escape BioSouth San Francisco, CA, USTherapeuticsest. 2015Escape BioSouth San Francisco, CA, US · est. 2015

ESCAPE Bio: A preclinical biopharmaceutical company developing therapies for neurodegenerative diseases.

Series D · $187.1M39

ViriomSan Diego, CA, USHBV Treatments, HIV Treatmentsest. 2009

ViriomSan Diego, CA, US · est. 2009

Viriom: A therapeutic biotech firm innovating treatments for HIV and Hepatitis B.

Series B · $35.4M200

TherabiolSan Francisco, CA, USImmune Therapiesest. 2012TherabiolSan Francisco, CA, US · est. 2012

Therabiol, Inc.: A San Francisco-based biotech firm specializing in developing immune therapies for viral infections.

Precision VirologicsSt. Louis, MO, USBiotechest. 2016Precision VirologicsSt. Louis, MO, US · est. 2016

Precision Virologics: A St. Louis-based biotech startup innovating in virology.

Intellia TherapeuticsCambridge, MA, USGene Editing, Therapiesest. 2014

Intellia TherapeuticsCambridge, MA, US · est. 2014

Cambridge-based Intellia Therapeutics pioneers gene editing therapies for genetic diseases.

Public · $1.2B598

Nvelop TherapeuticsCambridge, MA, USGene Editingest. 2022Nvelop TherapeuticsCambridge, MA, US · est. 2022

Cambridge-based Nvelop Therapeutics offers gene editing solutions for major unmet disease needs.

Seed · $100M12

Precision BioSciencesDurham, NC, USCancer Treatmentest. 2006Precision BioSciencesDurham, NC, US · est. 2006

US-based Precision Biosciences, Inc. is a biotech firm specializing in cancer treatment solutions.

Public · $225.2M198

4D HealthwareChicago, IL, US

Healthcare, Softwareest. 2012

4D HealthwareChicago, IL, US · est. 2012

4D Healthware: Empowering wellness through innovative preventive medicine software and technology.

Seed · $5.6M35

Trellis HealthSeattle, WA, USHealth Information Softwareest. 2022Trellis HealthSeattle, WA, US · est. 2022

Seattle-based software company, streamlining global health information for families.

Pre-Seed · $120k7

Avalon.aiNew York City, NY, USHealthcare Softwareest. 2015Avalon.aiNew York City, NY, US · est. 2015

AVALON.AI, a NYC-based software company, offers comprehensive enterprise solutions for all sectors.

Seed · $1.5M30

1910

Boston, MA, US

Drug Discoveryest. 2018

1910Boston, MA, US · est. 2018

1910 develops AI-enabled small and large molecule therapeutics through computational biology and laboratory automation.

Series A · $26.9M22

PotatoIssaquah, WA, USAI Infrastructureest. 2023PotatoIssaquah, WA, US · est. 2023

Issaquah-based software company, Potato, innovates AI infrastructure to streamline model pipelines.

Isomorphic LabsLondon, GBest. 2021Isomorphic LabsLondon, GB · est. 2021

Isomorphic Labs is an Alphabet-backed biotechnology company pioneering AI-driven drug discovery with a unified drug design engine.

Series B · $2.8B201-500 employees

Resilience TherapeuticsDuxbury, MA, USTherapeuticsest. 2014

Resilience TherapeuticsDuxbury, MA, US · est. 2014

Resilience Therapeutics: Innovating cures for PTSD and stress-related diseases through proprietary drug discovery.

Seed · $3.4M5

Bright Path LaboratoriesKannapolis, NC, USPharmaceutical Manufacturingest. 2019Bright Path LaboratoriesKannapolis, NC, US · est. 2019

Bright Path Labs: Agile, scalable pharmaceutical manufacturing tech provider, addressing drug shortages and future health challenges.

Continuity PharmaWest Lafayette, IN, USManufacturing Systemsest. 2018Continuity PharmaWest Lafayette, IN, US · est. 2018

Continuity Pharma: Modern, efficient systems for manufacturing essential generic medicines.

Encoded TherapeuticsSouth San Francisco, CA, USPrecision Therapiesest. 2014

Encoded TherapeuticsSouth San Francisco, CA, US · est. 2014

Encoded: Leveraging human genome power for effective precision therapies in genetic disorders.

Series D · $239.1M200

Moma TherapeuticsCambridge, MA, USPrecision Medicinesest. 2020Moma TherapeuticsCambridge, MA, US · est. 2020

MOMA Therapeutics, a biotech firm, is dedicated to discovering precision medicines by unlocking molecular complexities.

Series B · $236M75

Denali TherapeuticsSan Francisco, CA, USBiotechest. 2015Denali TherapeuticsSan Francisco, CA, US · est. 2015

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.

Public · $622M427

Guardant HealthPalo Alto, CA, USCancer Diagnosticsest. 2011

Guardant HealthPalo Alto, CA, US · est. 2011

Guardant Health: A Palo Alto-based biotech firm providing global cancer diagnostics and sequencing services.

Public1.8k

CirinaMenlo Park, CA, USCancer Detectionest. 2014CirinaMenlo Park, CA, US · est. 2014

Cirina, Inc.: California-based provider of early cancer detection through blood plasma tests.

Series A · $12M30

Early DetectionSan Diego, CA, USCancerscreeningest. 2017Early DetectionSan Diego, CA, US · est. 2017

Early Detection, founded in 2017, develops non-invasive, accurate cancer screening tests in San Diego.

Sapphire TechnologiesCerritos, CA, US

Energy Recovery Systemsest. 2021

Sapphire TechnologiesCerritos, CA, US · est. 2021

Sapphire Technologies: Leading manufacturer of energy recovery systems for gas and hydrogen applications.

Series B · $10M23

Renewable Fuel ProductsBiomass, Renewable Energyest. 2007Renewable Fuel Productsest. 2007

Renewable Fuel Products, Inc: A startup pioneering in renewable energy alternatives and algae biomass systems.

Keyspan EnergyMelville, NY, USEnergy Servicesest. 1998Keyspan EnergyMelville, NY, US · est. 1998

Leading green energy provider using bio-fuel.

Public · $200k2.8k